Switzerland's Ferring Pharma to build $32M discovery, development and manufacturing center at HQ
Expanding its global headquarters in Switzerland, Ferring Pharmaceuticals is investing 30 million Swiss francs (roughly $32 million) in a new biotech center.
In addition to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.